Clinical trial

GlycoQuest: An AI-Adaptive CGM-Integrated Serious Game for Pediatric Type 1 Diabetes

NCT07726680

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BEHAVIORAL · Unmapped registry intervention GlycoQuest Digital Therapeutic Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Enhanced Digital Psychoeducation Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

GlycoQuest: An AI-Adaptive CGM-Integrated Serious Game for Pediatric Type 1 Diabetes

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-06-01

PhaseNA

Conditions

Type 1 Diabetes Mellitus (T1DM)unresolved

Diabetes Distressunresolved

Hypoglycemia (Diabetic)unresolved

Family Conflictunresolved

Interventions

GlycoQuest Digital TherapeuticBEHAVIORAL

Enhanced Digital PsychoeducationBEHAVIORAL

Sponsors & collaborators

Shifa International Hospitallead sponsor

Al Ain Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07726680 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.